398 related articles for article (PubMed ID: 26278786)
1. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells.
Ohkubo K; Sakai Y; Inoue H; Akamine S; Ishizaki Y; Matsushita Y; Sanefuji M; Torisu H; Ihara K; Sardiello M; Hara T
Sci Rep; 2015 Aug; 5():13191. PubMed ID: 26278786
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.
Kobayashi H; Matsuda Y; Hitomi T; Okuda H; Shioi H; Matsuda T; Imai H; Sone M; Taura D; Harada KH; Habu T; Takagi Y; Miyamoto S; Koizumi A
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26126547
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.
Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A
Biochem Biophys Res Commun; 2013 Aug; 438(1):13-9. PubMed ID: 23850618
[TBL] [Abstract][Full Text] [Related]
4. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease.
Kanoke A; Fujimura M; Niizuma K; Fujimura T; Kakizaki A; Ito A; Sakata H; Sato-Maeda M; Kure S; Tominaga T
Brain Res; 2016 Jul; 1642():1-9. PubMed ID: 26972532
[TBL] [Abstract][Full Text] [Related]
5. Loss of mitochondrial ClpP, Lonp1, and Tfam triggers transcriptional induction of Rnf213, a susceptibility factor for moyamoya disease.
Key J; Maletzko A; Kohli A; Gispert S; Torres-Odio S; Wittig I; Heidler J; Bárcena C; López-Otín C; Lei Y; West AP; Münch C; Auburger G
Neurogenetics; 2020 Jul; 21(3):187-203. PubMed ID: 32342250
[TBL] [Abstract][Full Text] [Related]
6. Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene.
Sonobe S; Fujimura M; Niizuma K; Fujimura T; Furudate S; Nishijima Y; Kure S; Tominaga T
Neuroreport; 2014 Dec; 25(18):1442-6. PubMed ID: 25383461
[TBL] [Abstract][Full Text] [Related]
7. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease.
Kanoke A; Fujimura M; Niizuma K; Ito A; Sakata H; Sato-Maeda M; Morita-Fujimura Y; Kure S; Tominaga T
Brain Res; 2015 Oct; 1624():497-505. PubMed ID: 26315378
[TBL] [Abstract][Full Text] [Related]
8. The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality.
Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A
Biochem Biophys Res Commun; 2013 Oct; 439(4):419-26. PubMed ID: 23994138
[TBL] [Abstract][Full Text] [Related]
9. RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway.
Ye F; Niu X; Liang F; Dai Y; Liang J; Li J; Wu X; Zheng H; Qi T; Sheng W
Brain; 2023 Nov; 146(11):4674-4689. PubMed ID: 37399508
[TBL] [Abstract][Full Text] [Related]
10. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease.
Sonobe S; Fujimura M; Niizuma K; Nishijima Y; Ito A; Shimizu H; Kikuchi A; Arai-Ichinoi N; Kure S; Tominaga T
Brain Res; 2014 Mar; 1552():64-71. PubMed ID: 24440776
[TBL] [Abstract][Full Text] [Related]
11. Knockdown the moyamoya disease susceptibility gene, RNF213, upregulates the expression of basic fibroblast growth factor and matrix metalloproteinase-9 in bone marrow derived mesenchymal stem cells.
Li Z; Liu Y; Li X; Yang S; Feng S; Li G; Jin F; Nie S
Neurosurg Rev; 2024 May; 47(1):246. PubMed ID: 38811382
[TBL] [Abstract][Full Text] [Related]
12. A new horizon of moyamoya disease and associated health risks explored through RNF213.
Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
[TBL] [Abstract][Full Text] [Related]
13. Transient middle cerebral artery occlusion in mice induces neuronal expression of RNF213, a susceptibility gene for moyamoya disease.
Sato-Maeda M; Fujimura M; Kanoke A; Morita-Fujimura Y; Niizuma K; Tominaga T
Brain Res; 2016 Jan; 1630():50-5. PubMed ID: 26556774
[TBL] [Abstract][Full Text] [Related]
14. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism.
Ahel J; Lehner A; Vogel A; Schleiffer A; Meinhart A; Haselbach D; Clausen T
Elife; 2020 Jun; 9():. PubMed ID: 32573437
[TBL] [Abstract][Full Text] [Related]
15. RNF213 loss of function reshapes vascular transcriptome and spliceosome leading to disrupted angiogenesis and aggravated vascular inflammatory responses.
Zhang L; Rashad S; Zhou Y; Niizuma K; Tominaga T
J Cereb Blood Flow Metab; 2022 Nov; 42(11):2107-2122. PubMed ID: 35754359
[TBL] [Abstract][Full Text] [Related]
16. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
[TBL] [Abstract][Full Text] [Related]
17. RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients.
Kobayashi H; Brozman M; Kyselová K; Viszlayová D; Morimoto T; Roubec M; Školoudík D; Petrovičová A; Juskanič D; Strauss J; Halaj M; Kurray P; Hranai M; Harada KH; Inoue S; Yoshida Y; Habu T; Herzig R; Youssefian S; Koizumi A
PLoS One; 2016; 11(10):e0164759. PubMed ID: 27736983
[TBL] [Abstract][Full Text] [Related]
18. New insights into TNFα/PTP1B and PPARγ pathway through RNF213- a link between inflammation, obesity, insulin resistance, and Moyamoya disease.
Sarkar P; Thirumurugan K
Gene; 2021 Mar; 771():145340. PubMed ID: 33333224
[TBL] [Abstract][Full Text] [Related]
19. Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease.
Ito A; Fujimura M; Niizuma K; Kanoke A; Sakata H; Morita-Fujimura Y; Kikuchi A; Kure S; Tominaga T
Brain Res; 2015 Jan; 1594():310-20. PubMed ID: 25446450
[TBL] [Abstract][Full Text] [Related]
20. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
